.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Oral presentation
51

Pre-operative medication assessment and optimization to improve clinical outcomes of women with ovarian cancer: subproject of the prospective KORE-INNOVATION trial.

Appointment

Date: 08/03/2023

Time: 10:15 – 10:30

Talk time: 10 Min.

Discussion time: 5 Min.

Location / Stream:

Session

Pharmacoepidemiology and drug safety

Topic

Pharmacoepidemiology and drug safety

Authors

Fabian Meinert (Berlin / DE), Engi Algharably (Berlin / DE), Reinhold Kreutz (Berlin / DE), Turan I. (Berlin / DE), M. Lee (Berlin / DE), M. E. Liebl (Berlin / DE), P. Harter (Essen / DE), Steffen Schneider (Essen / DE), E. Schnura (Essen / DE), J. Klews (Berlin / DE), R. Lohrmann (Berlin / DE), L. Zwanzleitner (... / DE), J. Sehouli (Berlin / DE)